메뉴 건너뛰기
Modern Rheumatology
Volumn 16, Issue 4, 2006, Pages 251-255
Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α-neutralizing antibody
Author keywords

Infliximab; Interstitial pneumonia (IP); Methotrexate (MTX); Rheumatoid arthritis (RA); Tumor necrosis factor (TNF)
Indexed keywords

COTRIMOXAZOLE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPINASTINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISOLONE; PREDNISONE; STEROID; TUMOR NECROSIS FACTOR ANTIBODY;
EID: 33747312637     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0491-5     Document Type: Article
Times cited : (23)
References (13)
  • 1
    • 0034735827 scopus 로고    scopus 로고
    • A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
    • 11096165 1:CAS:528:DC%2BD3cXovVeltLg%3D 10.1056/NEJM200011303432201
    • JM Bathon RW Martin RM Fleischmann JR Tesser MH Schiff EC Keystone 2000 A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis N Engl J Med 343 1586-93 11096165 1:CAS:528:DC%2BD3cXovVeltLg%3D 10.1056/NEJM200011303432201
    • (2000) N Engl J Med , vol.343 , pp. 1586-1593
    • Bathon, J.M.1    Martin, R.W.2    Fleischmann, R.M.3    Tesser, J.R.4    Schiff, M.H.5    Keystone, E.C.6
  • 2
    • 10744223002 scopus 로고    scopus 로고
    • Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial
    • 15001324 1:CAS:528:DC%2BD2cXhs12jur4%3D 10.1016/S0140-6736(04)15640-7
    • L Klareskog D van der Heijde JP De Jager A Gough J Kalden M Malaise 2004 Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial Lancet 363 675-81 15001324 1:CAS:528:DC%2BD2cXhs12jur4%3D 10.1016/S0140-6736(04)15640-7
    • (2004) Lancet , vol.363 , pp. 675-681
    • Klareskog, L.1    van der Heijde, D.2    De Jager, J.P.3    Gough, A.4    Kalden, J.5    Malaise, M.6
  • 3
    • 0034735842 scopus 로고    scopus 로고
    • Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
    • 11096166 1:CAS:528:DC%2BD3cXovVeltLk%3D 10.1056/NEJM200011303432202
    • PE Lipsky DM van der Heijde EW St Clair DE Furst FC Breedveld JR Kalden 2000 Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group N Engl J Med 343 1594-602 11096166 1:CAS:528:DC%2BD3cXovVeltLk%3D 10.1056/NEJM200011303432202
    • (2000) N Engl J Med , vol.343 , pp. 1594-1602
    • Lipsky, P.E.1    van der Heijde, D.M.2    St Clair, E.W.3    Furst, D.E.4    Breedveld, F.C.5    Kalden, J.R.6
  • 4
    • 8444239359 scopus 로고    scopus 로고
    • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
    • 15529377 1:CAS:528:DC%2BD2cXhtVOqtrvJ 10.1002/art.20568
    • EW St Clair DM van der Heijde JS Smolen RN Maini JM Bathon P Emery 2004 Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial Arthritis Rheum 50 3432-3 15529377 1:CAS:528:DC%2BD2cXhtVOqtrvJ 10.1002/art.20568
    • (2004) Arthritis Rheum , vol.50 , pp. 3432-3433
    • St Clair, E.W.1    van der Heijde, D.M.2    Smolen, J.S.3    Maini, R.N.4    Bathon, J.M.5    Emery, P.6
  • 5
    • 33645781864 scopus 로고    scopus 로고
    • Comparison of adverse event reporting rates for etanercept, infliximab, leflunomide and methotrexate between September 1998 and June 2003
    • G Cannon V Strand L Scarazzini W Holden 2004 Comparison of adverse event reporting rates for etanercept, infliximab, leflunomide and methotrexate between September 1998 and June 2003 Arthritis Rheum Suppl 50 S561
    • (2004) Arthritis Rheum Suppl , vol.50
    • Cannon, G.1    Strand, V.2    Scarazzini, L.3    Holden, W.4
  • 6
    • 4444262694 scopus 로고    scopus 로고
    • Severe interstitial pneumonitis associated with infliximab therapy
    • 15370726 1:STN:280:DC%2BD2cvmt12qug%3D%3D 10.1080/03009740410005836
    • S Chatterjee 2004 Severe interstitial pneumonitis associated with infliximab therapy Scand J Rheumatol 33 276-7 15370726 1:STN:280:DC%2BD2cvmt12qug%3D%3D 10.1080/03009740410005836
    • (2004) Scand J Rheumatol , vol.33 , pp. 276-277
    • Chatterjee, S.1
  • 7
    • 0042736048 scopus 로고    scopus 로고
    • Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis
    • 12910574 10.1002/art.11187 author reply 617-8
    • PA Courtney J Alderdice EM Whitehead 2003 Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis Arthritis Rheum 49 61712910574 10.1002/art.11187 author reply 617-8
    • (2003) Arthritis Rheum , vol.49 , pp. 617
    • Courtney, P.A.1    Alderdice, J.2    Whitehead, E.M.3
  • 8
    • 0037114932 scopus 로고    scopus 로고
    • Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis
    • 12522843 10.1002/art.10803
    • N Kramer Y Chuzhin LD Kaufman JM Ritter ED Rosenstein 2002 Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis Arthritis Rheum 47 670-1 12522843 10.1002/art.10803
    • (2002) Arthritis Rheum , vol.47 , pp. 670-671
    • Kramer, N.1    Chuzhin, Y.2    Kaufman, L.D.3    Ritter, J.M.4    Rosenstein, E.D.5
  • 9
    • 9644264083 scopus 로고    scopus 로고
    • Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab
    • 15564258 10.1136/bmj.329.7477.1266
    • AJ Ostor AJ Crisp MF Somerville DG Scott 2004 Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab BMJ 329 126615564258 10.1136/bmj.329.7477.1266
    • (2004) BMJ , vol.329 , pp. 1266
    • Ostor, A.J.1    Crisp, A.J.2    Somerville, M.F.3    Scott, D.G.4
  • 10
  • 11
    • 24144477565 scopus 로고    scopus 로고
    • Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis
    • 1:CAS:528:DC%2BD2MXovVKrtbs%3D 10.1093/rheumatology/keh696
    • J Torre-Cisneros M Del Castillo JJ Caston MC Castro V Perez E Collantes 2005 Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis Rheumatology (Oxford) 44 1132-5 1:CAS:528:DC%2BD2MXovVKrtbs%3D 10.1093/ rheumatology/keh696
    • (2005) Rheumatology (Oxford) , vol.44 , pp. 1132-1135
    • Torre-Cisneros, J.1    Del Castillo, M.2    Caston, J.J.3    Castro, M.C.4    Perez, V.5    Collantes, E.6
  • 12
    • 17044442903 scopus 로고    scopus 로고
    • Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group
    • 9273826 1:STN:280:ByiH3M%2FnsV0%3D
    • GS Alarcon JM Kremer M Macaluso ME Weinblatt GW Cannon WR Palmer 1997 Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group Ann Intern Med 127 356-64 9273826 1:STN:280:ByiH3M%2FnsV0%3D
    • (1997) Ann Intern Med , vol.127 , pp. 356-364
    • Alarcon, G.S.1    Kremer, J.M.2    Macaluso, M.3    Weinblatt, M.E.4    Cannon, G.W.5    Palmer, W.R.6
  • 13
    • 0037218733 scopus 로고    scopus 로고
    • Repression of bleomycin-induced pneumopathy by TNF
    • 12496444 1:CAS:528:DC%2BD3sXhtFKhtQ%3D%3D
    • M Kuroki Y Noguchi M Shimono K Tomono T Tashiro Y Obata 2003 Repression of bleomycin-induced pneumopathy by TNF J Immunol 170 567-74 12496444 1:CAS:528:DC%2BD3sXhtFKhtQ%3D%3D
    • (2003) J Immunol , vol.170 , pp. 567-574
    • Kuroki, M.1    Noguchi, Y.2    Shimono, M.3    Tomono, K.4    Tashiro, T.5    Obata, Y.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.